Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Veracyte (VCYT)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Veracyte (VCYT – Research Report). Vertex Pharmaceuticals (VRTX) Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Vertex Pharmaceuticals today and set a price target of $202.00. The company's shares closed last Friday at $201.58, close to its 52-week low of $185.33. According to TipRanks.com, Harrison is a 5-star analyst with an average return of 15.1% and a 58.7% success rate. Harrison covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Cerevel Therapeutics Holdings, and Centessa Pharmaceuticals. Vertex Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $262.36, implying a 30.2% upside from current levels. In a report released today, Needham also assigned a Hold rating to the stock. See today’s analyst top recommended stocks >> Veracyte (VCYT) In a report released today, Tejas Savant from Morgan Stanley maintained a Sell rating on Veracyte, with a price target of $42.00. The company's shares closed last Friday at $44.56. According to TipRanks.com, Savant is a 3-star analyst with an average return of 9.5% and a 55.9% success rate. Savant covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Akoya Biosciences, and Guardant Health. Currently, the analyst consensus on Veracyte is a Moderate Buy with an average price target of $59.00. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Read More on VRTX: Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH) Analysts’ Top Technology Picks: Plantronics (POLY), WEX (WEX) Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and United Rentals (URI) Needham Sticks to Their Buy Rating for Bel Fuse (BELFA) Barrington Keeps Their Buy Rating on Superior Uniform Group (SGC) The post Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Veracyte (VCYT) appeared first on TipRanks Financial Blog.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Veracyte (VCYT – Research Report).

Vertex Pharmaceuticals (VRTX)

Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Vertex Pharmaceuticals today and set a price target of $202.00. The company's shares closed last Friday at $201.58, close to its 52-week low of $185.33.

According to TipRanks.com, Harrison is a 5-star analyst with an average return of 15.1% and a 58.7% success rate. Harrison covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Cerevel Therapeutics Holdings, and Centessa Pharmaceuticals.

Vertex Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $262.36, implying a 30.2% upside from current levels. In a report released today, Needham also assigned a Hold rating to the stock.

Veracyte (VCYT)

In a report released today, Tejas Savant from Morgan Stanley maintained a Sell rating on Veracyte, with a price target of $42.00. The company's shares closed last Friday at $44.56.

According to TipRanks.com, Savant is a 3-star analyst with an average return of 9.5% and a 55.9% success rate. Savant covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Akoya Biosciences, and Guardant Health.

Currently, the analyst consensus on Veracyte is a Moderate Buy with an average price target of $59.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on VRTX:

  • Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH)
  • Analysts’ Top Technology Picks: Plantronics (POLY), WEX (WEX)
  • Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and United Rentals (URI)
  • Needham Sticks to Their Buy Rating for Bel Fuse (BELFA)
  • Barrington Keeps Their Buy Rating on Superior Uniform Group (SGC)

The post Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Veracyte (VCYT) appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0

Next Article

Nielsen Holdings (NLSN) Gets a Hold Rating from Morgan Stanley

In a report released today, Toni Kaplan from Morgan Stanley maintained a Hold rating on Nielsen Holdings (NLSN – Research Report), with a price target of $27.00. The company's shares closed last Friday at $23.69. According to TipRanks.com, Kaplan is a 2-star analyst with an average return of 1.1% and a 49.7% success rate. Kaplan covers the Services sector, focusing on stocks such as Bright Horizons, Clarivate, and Gartner. Nielsen Holdings has an analyst consensus of Hold, with a price target consensus of $28.40. See today’s analyst top recommended stocks >> The company has a one-year high of $28.42 and a one-year low of $13.13. Currently, Nielsen Holdings has an average volume of 2.61M. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Nielsen Holdings Plc engages in the provision of global marketing data collection and analytics services. It operates through the Buy and Watch segments. The Buy segments offers consumer packaged goods to manufacturers and retailers. The Watch segment delivers services to media and advertising clients. The company was founded by Arthur C. Nielsen, Sr. in 1923 and is headquartered in New York, NY. Read More on NLSN: Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Veracyte (VCYT) Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH) Analysts’ Top Technology Picks: Plantronics (POLY), WEX (WEX) Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and United Rentals (URI) Needham Sticks to Their Buy Rating for Bel Fuse (BELFA) The post Nielsen Holdings (NLSN) Gets a Hold Rating from Morgan Stanley appeared first on TipRanks Financial Blog.

In a report released today, Toni Kaplan from Morgan Stanley maintained a Hold rating on Nielsen Holdings (NLSN – Research Report), with a price target of $27.00. The company's shares closed last Friday at $23.69.

According to TipRanks.com, Kaplan is a 2-star analyst with an average return of 1.1% and a 49.7% success rate. Kaplan covers the Services sector, focusing on stocks such as Bright Horizons, Clarivate, and Gartner.

Nielsen Holdings has an analyst consensus of Hold, with a price target consensus of $28.40.

The company has a one-year high of $28.42 and a one-year low of $13.13. Currently, Nielsen Holdings has an average volume of 2.61M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Nielsen Holdings Plc engages in the provision of global marketing data collection and analytics services. It operates through the Buy and Watch segments. The Buy segments offers consumer packaged goods to manufacturers and retailers. The Watch segment delivers services to media and advertising clients. The company was founded by Arthur C. Nielsen, Sr. in 1923 and is headquartered in New York, NY.

Read More on NLSN:

  • Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Veracyte (VCYT)
  • Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH)
  • Analysts’ Top Technology Picks: Plantronics (POLY), WEX (WEX)
  • Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and United Rentals (URI)
  • Needham Sticks to Their Buy Rating for Bel Fuse (BELFA)

The post Nielsen Holdings (NLSN) Gets a Hold Rating from Morgan Stanley appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.